R&D expenses of Bausch Health 2013-2023
This statistic shows research and development expenses by Bausch Health from 2014 to 2023. The R&D expenses by Bausch Health were at 246 million U.S. dollars in 2014, and 604 million dollars in 2023. Bausch Health Companies Inc. was known as Valeant Pharmaceuticals until July 2018 when the name was changed under a new company leadership.